A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia
Since the COVID-19 vaccines have been approved, worldwide reports of adverse events have been reported. Although a few cases of Psoriasis vulgaris have been reported after COVID-10 vaccination, there is currently limited evidence to establish a direct relationship between the vaccine and this condit...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Padjajaran
2025-03-01
|
| Series: | Majalah Kedokteran Bandung |
| Subjects: | |
| Online Access: | https://journal.fk.unpad.ac.id/index.php/mkb/article/view/3855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849247318612639744 |
|---|---|
| author | Hassan Alwafi Nedaa Alsulaimani Mohammed E. Almalki Asma Mohammad Banjar Reham Abdullah Alamri Danya Alwafi Anan S. Jarab Asaleh El-Qasem Yosra J. Alhartani Abdallah Y Naser |
| author_facet | Hassan Alwafi Nedaa Alsulaimani Mohammed E. Almalki Asma Mohammad Banjar Reham Abdullah Alamri Danya Alwafi Anan S. Jarab Asaleh El-Qasem Yosra J. Alhartani Abdallah Y Naser |
| author_sort | Hassan Alwafi |
| collection | DOAJ |
| description | Since the COVID-19 vaccines have been approved, worldwide reports of adverse events have been reported. Although a few cases of Psoriasis vulgaris have been reported after COVID-10 vaccination, there is currently limited evidence to establish a direct relationship between the vaccine and this condition. A 27-year-old Saudi woman, previously healthy and had no medical issues, reported skin lesions on her lower legs, which she noticed ten (10) days after receiving the first dose of the Pfizer COVID-19 vaccine. The patient had no prior history of such lesions or any family history of psoriasis. Joint pain was not observed. A diagnosis of psoriasis vulgaris was made, and the patient was treated with Daivobet® cream, urea cream 10%, and full-body NB-UVB light therapy three times a week for up to two months. The patient's condition improved partially. This report presents the first known case of psoriasis vulgaris after the COVID-19 vaccine in the Middle East. Further research is needed to fully understand this connection. The study emphasizes the significance of a thorough medical history and evaluation for precise diagnosis and treatment. |
| format | Article |
| id | doaj-art-71894c49fc5b4e85bf95c2d79d74154f |
| institution | Kabale University |
| issn | 0126-074X 2338-6223 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Universitas Padjajaran |
| record_format | Article |
| series | Majalah Kedokteran Bandung |
| spelling | doaj-art-71894c49fc5b4e85bf95c2d79d74154f2025-08-20T03:58:14ZengUniversitas PadjajaranMajalah Kedokteran Bandung0126-074X2338-62232025-03-01571818610.15395/mkb.v57.38551834A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi ArabiaHassan Alwafi0Nedaa Alsulaimani1Mohammed E. Almalki2Asma Mohammad Banjar3Reham Abdullah Alamri4Danya Alwafi5Anan S. Jarab6Asaleh El-Qasem7Yosra J. Alhartani8Abdallah Y Naser9Pharmacology and Toxicology Department, Faculty of Medicine, Umm Al Qura University, MakkahDepartment of Medicine and Surgery, Faculty of Medicine, Umm Al-Qura University, MakkahDepartment of Medicine and Surgery, Faculty of Medicine, Umm Al-Qura University, MakkahFaculty of Pharmacy, Umm Al Qura University, MakkahDepartment of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University, MakkahDepartment of Dermatology, Al-Noor Specialist Hospital, Ministry of Health, Makkah- College of Pharmacy, Al Ain University, Abu Dhabi P.O. Box 112612, United Arab Emirates - AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi P.O. Box 112612, United Arab Emirates - Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JordanFaculty of Pharmacy, University of Jordan, Amman, JordanDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, AmmanDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, AmmaSince the COVID-19 vaccines have been approved, worldwide reports of adverse events have been reported. Although a few cases of Psoriasis vulgaris have been reported after COVID-10 vaccination, there is currently limited evidence to establish a direct relationship between the vaccine and this condition. A 27-year-old Saudi woman, previously healthy and had no medical issues, reported skin lesions on her lower legs, which she noticed ten (10) days after receiving the first dose of the Pfizer COVID-19 vaccine. The patient had no prior history of such lesions or any family history of psoriasis. Joint pain was not observed. A diagnosis of psoriasis vulgaris was made, and the patient was treated with Daivobet® cream, urea cream 10%, and full-body NB-UVB light therapy three times a week for up to two months. The patient's condition improved partially. This report presents the first known case of psoriasis vulgaris after the COVID-19 vaccine in the Middle East. Further research is needed to fully understand this connection. The study emphasizes the significance of a thorough medical history and evaluation for precise diagnosis and treatment.https://journal.fk.unpad.ac.id/index.php/mkb/article/view/3855drug-related side effects and adverse reactionscovid-19sars-cov-2vaccinesvulgaris |
| spellingShingle | Hassan Alwafi Nedaa Alsulaimani Mohammed E. Almalki Asma Mohammad Banjar Reham Abdullah Alamri Danya Alwafi Anan S. Jarab Asaleh El-Qasem Yosra J. Alhartani Abdallah Y Naser A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia Majalah Kedokteran Bandung drug-related side effects and adverse reactions covid-19 sars-cov-2 vaccines vulgaris |
| title | A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia |
| title_full | A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia |
| title_fullStr | A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia |
| title_full_unstemmed | A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia |
| title_short | A Case Study of Psoriasis Vulgaris After COVID-19 Vaccination in Saudi Arabia |
| title_sort | case study of psoriasis vulgaris after covid 19 vaccination in saudi arabia |
| topic | drug-related side effects and adverse reactions covid-19 sars-cov-2 vaccines vulgaris |
| url | https://journal.fk.unpad.ac.id/index.php/mkb/article/view/3855 |
| work_keys_str_mv | AT hassanalwafi acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT nedaaalsulaimani acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT mohammedealmalki acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT asmamohammadbanjar acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT rehamabdullahalamri acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT danyaalwafi acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT anansjarab acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT asalehelqasem acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT yosrajalhartani acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT abdallahynaser acasestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT hassanalwafi casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT nedaaalsulaimani casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT mohammedealmalki casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT asmamohammadbanjar casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT rehamabdullahalamri casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT danyaalwafi casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT anansjarab casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT asalehelqasem casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT yosrajalhartani casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia AT abdallahynaser casestudyofpsoriasisvulgarisaftercovid19vaccinationinsaudiarabia |